A Function for IL-7R for CD4+CD25+Foxp3+ T Regulatory Cells

Overview

Journal J Immunol

Specialty Allergy & Immunology

Date 2008 Jun 21

PMID 18566388

Citations 71

Authors

Allison L Bayer

Joon Youb Lee

Anabel de la Barrera

Charles D Surh

Thomas R Malek

Affiliations

Soon will be listed here.

Abstract

The IL-2/IL-2R interaction is important for development and peripheral homeostasis of T regulatory (Treg) cells. IL-2- and IL-2R-deficient mice are not completely devoid of Foxp3+ cells, but rather lack population of mature CD4+CD25+Foxp3high Treg cells and contain few immature CD4+CD25-Foxp3low T cells. Interestingly, common gamma chain (gammac) knockout mice have been shown to have a near complete absence of Foxp3+ Treg cells, including the immature CD25-Foxp3low subset. Therefore, other gammac-cytokine(s) must be critically important during thymic development of CD4+CD25+Foxp3+ Treg cells apart from the IL-2. The present study was undertaken to determine whether the gammac-cytokines IL-7 or IL-15 normally contribute to expression of Foxp3 and Treg cell production. These studies revealed that mice double deficient in IL-2Rbeta and IL-7Ralpha contained a striking lack in the CD4+Foxp3+ population and the Treg cell defect recapitulated the gammac knockout mice. In the absence of IL-7R signaling, IL-15/IL-15R interaction is dispensable for the production of CD4+CD25+Foxp3+ Treg cells, indicating that normal thymic Treg cell production likely depends on signaling through both IL-2 and IL-7 receptors. Selective thymic reconstitution of IL-2Rbeta in mice double deficient in IL-2Rbeta and IL-7Ralpha established that IL-2Rbeta is dominant and sufficient to restore production of Treg cells. Furthermore, the survival of peripheral CD4+Foxp3low cells in IL-2Rbeta-/- mice appears to depend upon IL-7R signaling. Collectively, these data indicate that IL-7R signaling contributes to Treg cell development and peripheral homeostasis.

Citing Articles

Metabolic reprogramming of naïve regulatory T cells by IL-7 and IL-15 promotes their persistence and performance upon adoptive transfer.

Filoni J, Ferrari A, Jofra T, Putignano A, Da Dalt L, Cesarano S Commun Biol. 2025; 8(1):99.

PMID: 39838096 PMC: 11751088. DOI: 10.1038/s42003-024-07381-1.

Neonatal immunity associated with heterologous HIV-1 neutralizing antibody induction in SHIV-infected Rhesus Macaques.

Holmes S, Li H, Shen X, Martin M, Tuck R, Chen Y Nat Commun. 2024; 15(1):10302.

PMID: 39604409 PMC: 11603298. DOI: 10.1038/s41467-024-54753-6.

Lymphotoxin limits Foxp3 regulatory T cell development from Foxp3 precursors via IL-4 signaling.

Borelli A, Santamaria J, Zamit C, Apert C, Chevallier J, Pierre P Nat Commun. 2024; 15(1):6976.

PMID: 39143070 PMC: 11324892. DOI: 10.1038/s41467-024-51164-5.

Adjusting to self in the thymus: CD4 versus CD8 lineage commitment and regulatory T cell development.

Baldwin I, Robey E J Exp Med. 2024; 221(10).

PMID: 38980291 PMC: 11232887. DOI: 10.1084/jem.20230896.

Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer.

Shouse A, LaPorte K, Malek T Immunity. 2024; 57(3):414-428.

PMID: 38479359 PMC: 11126276. DOI: 10.1016/j.immuni.2024.02.001.

References

Porter B, Scibelli P, Malek T . Control of T cell development in vivo by subdomains within the IL-7 receptor alpha-chain cytoplasmic tail. J Immunol. 2000; 166(1):262-9. DOI: 10.4049/jimmunol.166.1.262. View

Powrie F, Leach M, Mauze S, Caddle L, Coffman R . Phenotypically distinct subsets of CD4+ T cells induce or protect from chronic intestinal inflammation in C. B-17 scid mice. Int Immunol. 1993; 5(11):1461-71. DOI: 10.1093/intimm/5.11.1461. View

Zorn E, Nelson E, Mohseni M, Porcheray F, Kim H, Litsa D . IL-2 regulates FOXP3 expression in human CD4+CD25+ regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood. 2006; 108(5):1571-9. PMC: 1895505. DOI: 10.1182/blood-2006-02-004747. View

Watanabe N, Wang Y, Lee H, Ito T, Wang Y, Cao W . Hassall's corpuscles instruct dendritic cells to induce CD4+CD25+ regulatory T cells in human thymus. Nature. 2005; 436(7054):1181-5. DOI: 10.1038/nature03886. View

DCruz L, Klein L . Development and function of agonist-induced CD25+Foxp3+ regulatory T cells in the absence of interleukin 2 signaling. Nat Immunol. 2005; 6(11):1152-9. DOI: 10.1038/ni1264. View

Ziegler S, Liu Y . Thymic stromal lymphopoietin in normal and pathogenic T cell development and function. Nat Immunol. 2006; 7(7):709-14. DOI: 10.1038/ni1360. View

Zheng Y, Rudensky A . Foxp3 in control of the regulatory T cell lineage. Nat Immunol. 2007; 8(5):457-62. DOI: 10.1038/ni1455. View

Bayer A, Yu A, Malek T . Function of the IL-2R for thymic and peripheral CD4+CD25+ Foxp3+ T regulatory cells. J Immunol. 2007; 178(7):4062-71. DOI: 10.4049/jimmunol.178.7.4062. View

Al-Shami A, Spolski R, Kelly J, Fry T, Schwartzberg P, Pandey A . A role for thymic stromal lymphopoietin in CD4(+) T cell development. J Exp Med. 2004; 200(2):159-68. PMC: 2212020. DOI: 10.1084/jem.20031975. View

10.

Malek T, Bayer A . Tolerance, not immunity, crucially depends on IL-2. Nat Rev Immunol. 2004; 4(9):665-74. DOI: 10.1038/nri1435. View

11.

Lundmark F, Duvefelt K, Iacobaeus E, Kockum I, Wallstrom E, Khademi M . Variation in interleukin 7 receptor alpha chain (IL7R) influences risk of multiple sclerosis. Nat Genet. 2007; 39(9):1108-13. DOI: 10.1038/ng2106. View

12.

Liu W, Putnam A, Xu-Yu Z, Szot G, Lee M, Zhu S . CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006; 203(7):1701-11. PMC: 2118339. DOI: 10.1084/jem.20060772. View

13.

Tan J, Ernst B, Kieper W, Leroy E, Sprent J, Surh C . Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J Exp Med. 2002; 195(12):1523-32. PMC: 2193564. DOI: 10.1084/jem.20020066. View

14.

Soper D, Kasprowicz D, Ziegler S . IL-2Rbeta links IL-2R signaling with Foxp3 expression. Eur J Immunol. 2007; 37(7):1817-26. DOI: 10.1002/eji.200737101. View

15.

Seddiki N, Santner-Nanan B, Martinson J, Zaunders J, Sasson S, Landay A . Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med. 2006; 203(7):1693-700. PMC: 2118333. DOI: 10.1084/jem.20060468. View

16.

Lowe C, Cooper J, Brusko T, Walker N, Smyth D, Bailey R . Large-scale genetic fine mapping and genotype-phenotype associations implicate polymorphism in the IL2RA region in type 1 diabetes. Nat Genet. 2007; 39(9):1074-82. DOI: 10.1038/ng2102. View

17.

Rothenberg E . Spontaneous expression of interleukin-2 in vivo in specific tissues of young mice. Dev Immunol. 1998; 5(4):223-45. PMC: 2275993. DOI: 10.1155/1998/12421. View

18.

Lin J, Migone T, Tsang M, Friedmann M, Weatherbee J, Zhou L . The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity. 1995; 2(4):331-9. DOI: 10.1016/1074-7613(95)90141-8. View

19.

Burchill M, Yang J, Vogtenhuber C, Blazar B, Farrar M . IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol. 2006; 178(1):280-90. DOI: 10.4049/jimmunol.178.1.280. View

20.

Malek T, Yu A, Vincek V, Scibelli P, Kong L . CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity. 2002; 17(2):167-78. DOI: 10.1016/s1074-7613(02)00367-9. View